Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Montefiore Medical Center
Iambic Therapeutics, Inc
Bristol-Myers Squibb
Brigham and Women's Hospital
Blokhin's Russian Cancer Research Center
Hoffmann-La Roche
UMC Utrecht
Blokhin's Russian Cancer Research Center
Blokhin's Russian Cancer Research Center
Neonc Technologies, Inc.
Jonsson Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Adela, Inc